| Ytd | -37.24% | |
| 1y | -22.16% |
| Open | 5.21 | Prev Close | 5.12 | Low | 5.14 | High | 5.50 | Mkt Cap | 89.59M |
| Vol | 22.02K | Avg Vol | 43.84K | EPS | -0.82 | P/E | -6.36 | Forward P/E | -1.19 |
| Beta | 1.49 | Short Ratio | 3.19 | Inst. Own | 15.80% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-12 | 50-d Avg | 5.78 | 200-d Avg | 6.12 | 1yr Est | 6.33 |
VRCA News
Verrica Pharmaceuticals NASDAQ: VRCA reported second-quarter revenue growth in its YCANTH treatment
Verrica Pharmaceuticals Inc. (VRCA) Q2 2026 Earnings Call Transcript
WEST CHESTER, Pa., July 30, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the
Gainers Autonomix Medical (NASDAQ:AMIX) stock rose 49.1% to $4.1 during Tuesday's after-market
Under the terms of the Agreement, Verrica has granted Medomie an exclusive right to obtain and maint
WEST CHESTER, Pa., July 21, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasda
- Development Partner Torii Pharmaceutical also recently announced dosing of the first Japanese pati
WEST CHESTER, Pa., May 28, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq
WEST CHESTER, Pa., May 13, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq
Verrica Pharmaceuticals NASDAQ: VRCA reported higher first-quarter revenue and record demand for its
Verrica Pharmaceuticals Inc. (VRCA) Q1 2026 Earnings Call Transcript
Verrica Pharmaceuticals Inc. (VRCA) came out with a quarterly loss of $0.41 per share versus the Zac
– Company reports record demand for YCANTH® as dispensed applicator units grew to 15,302 in Q1 2026,
Phase 2 Data Highlight the Observed Abscopal-like Effect of VP-315 in Non-treated Basal Cell Carcino
WEST CHESTER, Pa., May 05, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the
WEST CHESTER, Pa., April 09, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasd
WEST CHESTER, Pa., April 06, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasd
Vivani Medical (NASDAQ: VANI - Get Free Report) and Verrica Pharmaceuticals (NASDAQ: VRCA - Get Free
LOS ANGELES--(BUSINESS WIRE)---- $VRCA--VRCA Investors Have the Opportunity to Join Investigation of
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces an investiga
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces an investiga
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings
Although U.S. stocks closed higher on Tuesday, there were a few notable insider trades.
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnin
Gainers Tupperware Brands Corporation (NYSE: TUP) shares jumped 59% to $1.43 on above-average vo
On Wednesday, 215 companies set new 52-week lows.
During Wednesday's trading, 435 companies set new 52-week lows.
Tuesday's session saw 211 companies set new 52-week lows.
During Thursday, 849 stocks hit new 52-week lows.
During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week
Tuesday morning saw 454 companies set new 52-week lows.
On Thursday morning, 420 companies hit new 52-week highs.
On Tuesday, 596 companies set new 52-week highs.
Stocks Which Set New 52-Week Low Yesterday Tues., Nov. 27, 2018
Stocks Which Set New 52-Week Low Yesterday, Mon., Nov. 26, 2018